The FDA's deadline on nitrosamine impurities are approaching quickly. In this webinar, Adare's Jason Brown examines the guidance in detail, looks at various approaches for reducing the presence of impurities, and demonstrates how Adare's unique nitrosamine mitigation process can help customers achieve compliance.
